April is Parkinson’s Awareness Month, a time to give special attention to a disease that affects approximately 100,000 Canadians. As a centre for both research and clinical treatment of Parkinson’s disease (PD), the Montreal Neurological Institute and Hospital (The Neuro) offers many specialized services and opportunities to participate in research to PD patients.
Multidisciplinary care and cutting-edge research share space at The Neuro
The Montreal Neurological Institute and Hospital (The Neuro) is recognized worldwide for its research and clinical expertise in Parkinson’s disease (PD). PD is a motor neuron disease that is generally associated with old age, but people can also develop it in their thirties and forties. Characteristic symptoms include tremor, rigidity and gait dysfunction, mood and sleep disorders, and cognitive degeneration. About 100,000 Canadians have PD.
Category:
Published on: 1 Apr 2017
The Montreal Neurological Institute and Hospital - The Neuro, at Ï㽶ÊÓƵ and the Ï㽶ÊÓƵ Health Centre, today announced a significant donation from Montreal-based technology firm that will enable the development of the world’s first chemical brain atlas. The Neuro team, led by neurosurgeon and research scientist Dr.
Category:
Published on: 21 Jan 2016
The Montreal Neurological Institute and Hospital - The Neuro, Ï㽶ÊÓƵ and the Ï㽶ÊÓƵ Health Centre, is at the forefront of Parkinson’s research and clinical care. Parkinson’s patients are seen at The Neuro’s Movement Disorders Clinic and the Montreal General Hospital. Approximately 100,000 Canadians have Parkinson’s disease.
The Neuro to introduce experimental drug treatment
Category:
Published on: 2 Apr 2015
